Table III.
Viral reactivations post-transplant.
| Type | n (%) |
|---|---|
| CMV reactivation requiring treatment | 11 (9%) |
| CMV IgG status (recipient/donor) | Positive/positive 8 Positive/negative 3 |
| EBV reactivation requiring treatment | 1 (1%) |
| HSV infection or reactivation | 2 (1·6%) |
| VZV reactivation | 12 (9·8%) |
| BK viruria | 1 (1%) |
CMV, cytomegalovirus; EBV, Epstein–Barr virus; HSV, herpes simplex virus; VZV, varicella zoster virus.